Ticker: APLS

Company: Apellis Pharmaceuticals, Inc.

Person: Cedric Francois, director, officer

Transaction date: Jan. 20, 2026

Reporting date: Jan. 21, 2026

Average share price: 19.7929

Sold 8182.0 shares for 161945.51